Biogen (BIIB) Interest Coverage Ratio: History & Chart

Biogen Inc.(BIIB)

Drug Manufacturers - General · Cambridge, MA

$214.64-2.72 (-1.25%)

Delayed quote: Sep 15, 2026, 10:20 AM EDT

About Biogen Inc.

Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while FUMADERM is available for the treatment of plaque psoriasis. Among its other key offerings is ADUHELM, specifically developed for Alzheimer's disease. The company also markets a selection of biosimilar drugs, including BENEPALI (an etanercept biosimilar akin to ENBREL), IMRALDI (an adalimumab biosimilar comparable to HUMIRA), and FLIXABI (an infliximab biosimilar referencing REMICADE). Further extending its therapeutic reach, Biogen supplies RITUXAN, prescribed for conditions like non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, certain types of ANCA-associated vasculitis, and pemphigus vulgaris. RITUXAN HYCELA targets non-Hodgkin's lymphoma and CLL, and GAZYVA is utilized for CLL and follicular lymphoma. OCREVUS addresses both relapsing and primary progressive forms of MS, complementing the company's broader efforts in anti-CD20 therapies. The company maintains a robust research and development pipeline, featuring numerous investigational therapies. These candidates are designed to tackle a wide spectrum of conditions, including multiple sclerosis and neuroimmunological disorders (e.g., BIIB135, BIIB061, BIIB091, BIIB107), Alzheimer's disease and other forms of dementia (e.g., Aducanumab, Lecanemab, BIIB076, BIIB080), neuromuscular disorders (e.g., BIIB067, BIIB078, BIIB105, BIIB100, BIIB110), Parkinson's disease and related movement disorders (e.g., BIIB124, BIIB094, BIIB118, BIIB101, BIIB122), neuropsychiatric conditions (e.g., BIIB125, BIIB104), immunology-related illnesses (e.g., Dapirolizumab pegol, BIIB059), acute neurological events (e.g., BIIB093, BIIB131), and neuropathic pain (e.g., BIIB074). Additionally, several biosimilar candidates, such as BYOOVIZ, BIIB800, and SB15, are progressing through various developmental stages. Biogen actively engages in strategic collaborations and licensing arrangements with various partners, including Acorda Therapeutics, Inc., Alkermes Pharma Ireland Limited, Denali Therapeutics Inc., Eisai Co., Ltd., Genentech, Inc., Neurimmune SubOne AG, Ionis Pharmaceuticals, Inc., Samsung Bioepis Co., Ltd., Sangamo Therapeutics, Inc., and Sage Therapeutics, Inc. Established in 1978, Biogen Inc. maintains its corporate headquarters in Cambridge, Massachusetts.

Cambridge, MA

7,500 employees

www.biogen.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Christopher A. Viehbacher

View full financials

BIIB Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

7.63x

INTEREST COVERAGE RATIO AVG TTM

5.22x

INTEREST COVERAGE RATIO AVG 3Y

8.29x

INTEREST COVERAGE RATIO AVG 5Y

9.18x

INTEREST COVERAGE RATIO AVG 10Y

16.91x

INTEREST COVERAGE RATIO AVG 15Y

29.06x

INTEREST COVERAGE RATIO AVG 20Y

26.34x

CURRENT VS TTM AVG

+46.13%

CURRENT VS 3Y AVG

-7.97%

CURRENT VS 5Y AVG

-16.89%

CURRENT VS 10Y AVG

-54.88%

CURRENT VS 15Y AVG

-73.74%

CURRENT VS 20Y AVG

-71.03%

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+10.82%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Biogen Inc. (BIIB)	$31.71B	7.63x	5.22x	8.29x	9.18x
DexCom, Inc. (DXCM)vs ›	$32.10B	49.83x	40.70x	32.97x	24.93x
Waters Corporation (WAT)vs ›	$31.17B	12.84x	11.03x	12.05x	13.28x
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$32.58B	1.99x	1.99x	1.99x	1.99x
Zoetis Inc. (ZTS)vs ›	$30.66B	14.80x	14.41x	13.27x	12.34x
Alcon Inc. (ALC)vs ›	$32.88B	6.67x	7.13x	6.15x	5.89x
ResMed Inc. (RMD)vs ›	$33.27B	65.20x	99.43x	62.91x	55.69x
Centene Corp. (CNC)vs ›	$33.52B	-11.24x	4.28x	3.30x	3.63x
GE HealthCare Technologies Inc. (GEHC)vs ›	$28.96B	6.14x	5.67x	11.29x	26.04x
Medline Inc. (MDLN)vs ›	$27.38B	2.72x	2.21x	1.60x	1.60x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Biogen Inc. (BIIB)

$31.71B

7.63x

5.22x

8.29x

9.18x

DexCom, Inc. (DXCM)vs ›

$32.10B

49.83x

40.70x

32.97x

24.93x

Waters Corporation (WAT)vs ›

$31.17B

12.84x

11.03x

12.05x

13.28x

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$32.58B

1.99x

Zoetis Inc. (ZTS)vs ›

$30.66B

14.80x

14.41x

13.27x

12.34x

Alcon Inc. (ALC)vs ›

$32.88B

6.67x

7.13x

6.15x

5.89x

ResMed Inc. (RMD)vs ›

$33.27B

65.20x

99.43x

62.91x

55.69x

Centene Corp. (CNC)vs ›

$33.52B

-11.24x

4.28x

3.30x

3.63x

GE HealthCare Technologies Inc. (GEHC)vs ›

$28.96B

6.14x

5.67x

11.29x

26.04x

Medline Inc. (MDLN)vs ›

$27.38B

2.72x

2.21x

1.60x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Biogen Inc. (BIIB)?

The interest coverage ratio for BIIB stock is 7.63x.

Is Biogen Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 7.63x is 17% below its 5-year average of 9.18x, around the middle of its 5-year range (-0.84x–14.52x).

What is the TTM average interest coverage ratio for Biogen Inc. (BIIB)?

The TTM average interest coverage ratio for BIIB stock is 5.22x.

What is the 3Y average interest coverage ratio for Biogen Inc. (BIIB)?

The 3Y average interest coverage ratio for BIIB stock is 8.29x.

What is the 5Y average interest coverage ratio for Biogen Inc. (BIIB)?

The 5Y average interest coverage ratio for BIIB stock is 9.18x.

What is the 10Y average interest coverage ratio for Biogen Inc. (BIIB)?

The 10Y average interest coverage ratio for BIIB stock is 16.91x.

What is the 15Y average interest coverage ratio for Biogen Inc. (BIIB)?

The 15Y average interest coverage ratio for BIIB stock is 29.06x.

What is the 20Y average interest coverage ratio for Biogen Inc. (BIIB)?

The 20Y average interest coverage ratio for BIIB stock is 26.34x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	3.87x
2026-03-31	5.88x
2025-12-31	-0.84x
2025-09-30	9.11x
2025-06-30	8.10x
2025-03-31	12.21x
2024-12-31	8.48x
2024-09-30	9.65x
2024-06-30	5.98x
2024-03-31	9.98x
2023-12-31	7.17x
2023-09-30	5.03x
2023-06-30	14.05x
2023-03-31	9.19x
2022-12-31	10.19x
2022-09-30	14.52x
2022-06-30	14.23x
2022-03-31	7.93x
2021-12-31	7.65x
2021-09-30	12.06x
2021-06-30	8.35x
2021-03-31	15.05x
2020-12-31	-5.90x
2020-09-30	19.30x
2020-06-30	29.92x
2020-03-31	41.08x
2019-12-31	38.65x
2019-09-30	39.44x
2019-06-30	41.00x
2019-03-31	31.37x
2018-12-31	29.21x
2018-09-30	34.64x
2018-06-30	23.47x
2018-03-31	30.39x
2017-12-31	23.65x
2017-09-30	26.76x
2017-06-30	18.88x
2017-03-31	16.16x
2016-12-31	13.68x
2016-09-30	21.60x
2016-06-30	22.16x
2016-03-31	21.78x
2015-12-31	17.33x
2015-09-30	87.94x
2015-06-30	212.60x
2015-03-31	166.85x
2014-12-31	156.72x
2014-09-30	155.75x
2014-06-30	139.26x
2014-03-31	88.34x
2013-12-31	102.80x
2013-09-30	103.72x
2013-06-30	89.32x
2013-03-31	44.15x
2012-12-31	32.39x
2012-09-30	59.06x
2012-06-30	72.25x
2012-03-31	49.91x
2011-12-31	54.58x
2011-09-30	61.62x
2011-06-30	48.91x
2011-03-31	4.52x
2010-12-31	37.39x
2010-09-30	20.87x
2010-06-30	43.99x
2010-03-31	36.59x
2009-12-31	46.75x
2009-09-30	45.20x
2009-06-30	23.97x
2009-03-31	30.80x
2008-12-31	6.25x
2008-09-30	42.70x
2008-06-30	21.35x
2008-03-31	15.64x
2007-12-31	14.11x
2007-09-30	6.59x
2007-06-30	108.65x
2007-03-31	447.52x
2006-12-31	602.89x
2006-09-30	2666.59x
2006-06-30	-610.08x
2006-03-31	590.41x
2005-09-30	37.07x
2005-06-30	16.25x
2005-03-31	10.89x
2004-12-31	6.69x
2004-09-30	23.74x
2004-06-30	-0.43x
2004-03-31	-22.02x
2003-09-30	15.36x
2003-06-30	8.88x
2003-03-31	12.81x

DATE

INTEREST COVERAGE RATIO

2026-06-30

3.87x

2026-03-31

5.88x

2025-12-31

-0.84x

2025-09-30

9.11x

2025-06-30

8.10x

2025-03-31

12.21x

2024-12-31

8.48x

2024-09-30

9.65x

2024-06-30

5.98x

2024-03-31

9.98x

2023-12-31

7.17x

2023-09-30

5.03x

2023-06-30

14.05x

2023-03-31

9.19x

2022-12-31

10.19x

2022-09-30

14.52x

2022-06-30

14.23x

2022-03-31

7.93x

2021-12-31

7.65x

2021-09-30

12.06x

2021-06-30

8.35x

2021-03-31

15.05x

2020-12-31

-5.90x

2020-09-30

19.30x

2020-06-30

29.92x

2020-03-31

41.08x

2019-12-31

38.65x

2019-09-30

39.44x

2019-06-30

41.00x

2019-03-31

31.37x

2018-12-31

29.21x

2018-09-30

34.64x

2018-06-30

23.47x

2018-03-31

30.39x

2017-12-31

23.65x

2017-09-30

26.76x

2017-06-30

18.88x

2017-03-31

16.16x

2016-12-31

13.68x

2016-09-30

21.60x

2016-06-30

22.16x

2016-03-31

21.78x

2015-12-31

17.33x

2015-09-30

87.94x

2015-06-30

212.60x

2015-03-31

166.85x

2014-12-31

156.72x

2014-09-30

155.75x

2014-06-30

139.26x

2014-03-31

88.34x

2013-12-31

102.80x

2013-09-30

103.72x

2013-06-30

89.32x

2013-03-31

44.15x

2012-12-31

32.39x

2012-09-30

59.06x

2012-06-30

72.25x

2012-03-31

49.91x

2011-12-31

54.58x

2011-09-30

61.62x

2011-06-30

48.91x

2011-03-31

4.52x

2010-12-31

37.39x

2010-09-30

20.87x

2010-06-30

43.99x

2010-03-31

36.59x

2009-12-31

46.75x

2009-09-30

45.20x

2009-06-30

23.97x

2009-03-31

30.80x

2008-12-31

6.25x

2008-09-30

42.70x

2008-06-30

21.35x

2008-03-31

15.64x

2007-12-31

14.11x

2007-09-30

6.59x

2007-06-30

108.65x

2007-03-31

447.52x

2006-12-31

602.89x

2006-09-30

2666.59x

2006-06-30

-610.08x

2006-03-31

590.41x

2005-09-30

37.07x

2005-06-30

16.25x

2005-03-31

10.89x

2004-12-31

6.69x

2004-09-30

23.74x

2004-06-30

-0.43x

2004-03-31

-22.02x

2003-09-30

15.36x

2003-06-30

8.88x

2003-03-31

12.81x

Interest Coverage Ratio: 7.63x

BIIB Interest Coverage Ratio

BIIB Average Interest Coverage Ratio Chart

BIIB Current vs Average Interest Coverage Ratio Chart

BIIB Interest Coverage Ratio Metrics

BIIB Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

BIIB Interest Coverage Ratio History

Related Metrics